The future of patient-centered treatment and patient-response prediction in diseases like rheumatoid arthritis may follow the path forged by oncology and the molecular profiling of tumors, said Susan Goodman, MD, the co-moderator of a session on precision clinical trial design in rheumatoid arthritis.

The sessions in this track are targeted to a diverse audience that includes clinician-educators, program directors, division directors, and anyone actively involved in maintaining, recruiting, and sustaining the rheumatology workforce, explained Lisa Zickuhr, MD, MHPE.

Kaleb Michaud, PhD, has been a rheumatology researcher for more than 22 years, but his first experience with rheumatology was as a toddler when he received a diagnosis of rheumatoid arthritis.

The breadth of pediatric topics addressed in the scientific sessions reflects the multifaceted nature of the subspecialty, said Susan Shenoi, MD, MS. Some of the topics to be addressed include juvenile arthritis, lupus, juvenile dermatomyositis, vaccinations, rare diseases, and innovative models around mental health.

See what’s new from your industry, including medical advancements that will change patient care and biosimilars, as well as other clinical developments that are likely to have a significant impact.